Investor Summary
Fund Strategy
FUND PERFORMANCE AS OF 30th June 2026
| ANNUALIZED SINCE INCEPTION | QUARTERLY | YTD |
|---|---|---|
| 5.24% | 2.08% | - |
| ANNUALIZED SINCE INCEPTION | QUARTERLY | YTD |
|---|---|---|
| 5.24% | 2.08% | - |
The Gabelli ABC Fund delivered a 2.08% return in Q2 2026, outperforming its benchmark as global M&A activity reached record levels. Worldwide announced M&A value hit an all-time high of $2.85 trillion in the first half of 2026, up 50% year-over-year, with the second quarter alone delivering $1.6 trillion. This marked the fourth consecutive quarter above $1 trillion and the largest single quarter on record. Mega-deals over $10 billion totaled $1.3 trillion, more than double 2025 levels. Cash deals dominated at 63% of transactions. The Fund's top contributors included Rogers Corp., Myers Industries Inc., and Soleno Therapeutics Inc., while detractors included Pan American Silver Corp. and Fox Corp. Class B. The pipeline remains robust with pending deals including Catalyst Pharmaceuticals, Global Business Travel Group, and Taylor Morrison Home Corp. The Fund closed several transactions during the quarter including Janus Henderson Group and Masimo Corp. The strong M&A environment provides continued opportunities for the Fund's arbitrage-focused strategy.
The Gabelli ABC Fund pursues total returns that are attractive to investors in various market conditions without excessive risk of capital loss by focusing on arbitrage strategies in event-driven situations such as announced mergers, spin-offs, split-ups, liquidations, and reorganizations.
The Fund continues to focus on announced mergers, acquisitions, spin-offs, split-ups, liquidations, and reorganizations. The strong M&A environment with record deal activity and mega-transactions provides a robust pipeline of opportunities. The Fund may also hold a significant portion of its assets in U.S. Treasury bills in anticipation of quick, non-market correlated opportunities.
| Date | Letter | Tickers | Keywords | Pitches | Quick Takes |
|---|---|---|---|---|---|
| Aug 13 2026 | 2026 Q2 | ACA, CPRX, GBTG, MYE, OGN, ROKU, SOC, TMHC, TNDM | Acquisitions, arbitrage, Biotech, Cash deals, Event-Driven, M&A, Mega-deals, Mergers | - | The Gabelli ABC Fund gained 2.08% in Q2 2026 as global M&A hit record levels with $2.85 trillion in first-half deal value, up 50% year-over-year. Mega-deals totaled $1.3 trillion, more than doubling 2025 levels. Cash deals dominated at 63% of transactions. The Fund capitalized on event-driven opportunities including completed deals like Janus Henderson and a robust pipeline of pending transactions across biotech, homebuilding, and media sectors. |
| May 26 2026 | 2026 Q1 | ACLX, MASI | arbitrage, Biotechnology, Deal Activity, energy, Iran Conflict, M&A | - | Gabelli ABC Fund gained 1.65% in Q1 2026 from strong M&A activity totaling $1.2 trillion in deals, up 27% year-over-year. Arbitrage strategy benefited from biotech acquisitions and energy sector strength during Iran conflict. Fund positioned in pending deals including AES Corp and Tri Pointe Homes with continued M&A momentum expected. |
| Feb 18 2026 | 2025 Q4 | CFLT, EXAS, FOX, FRGE, GTLS, HOLX, KKR, KMB, KVUE, LEN, NEM, NFG, NFLX, PAAS, PSKY, TGNA, TXNM, WBD | arbitrage, healthcare, industrials, M&A, private equity, technology |
GTCH EXAS HOLX ALE |
The Gabelli ABC Fund gained 0.45% in Q4 amid record M&A activity totaling $4.6 trillion for 2025. The Fund capitalized on event-driven opportunities including major biotech acquisitions and megadeals like Netflix's Warner Bros. Discovery bid. Strong deal flow across technology, industrials, and financials sectors positions the strategy well for continued M&A momentum in 2026. |
| Nov 16 2025 | 2025 Q3 | AAPL, AMETEK, AMZN, AXP, BK, BRK.B, CAT, CNH, DE, GOOGL, ITT, META, MSFT, MSGS, NEM, NFLX, NVDA, RSG, SONY, TSLA, WBD | AI, energy, financials, gold, M&A, rates, technology, Trade |
ECG US OR US |
Markets climbed 8.1% in Q3 driven by AI enthusiasm and broadening rally despite trade tensions. Fed cut rates 25bps with more expected while gold hit $4,000 on fiscal concerns. M&A activity surged 33% as regulatory environment improved. Despite 30x earnings valuations, opportunities exist in overlooked small-mid caps using Private Market Value approach. |
| Jun 30 2025 | 2025 Q2 | AAPL, AMZN, BATRA, CHWY, CZR, FOX, GOOGL, IDXX, IVG.MI, META, MSFT, MSGS, NFLX, NVDA, SBGI, TDS, TGNA, TSLA, WBD, ZTS | AI, defense, Mergers & Acquisitions, private market value, Sports, tariffs, Utilities, Value Investing | SWTX | GAMCO navigates Q2 2025's policy-driven volatility through disciplined Private Market Value investing. Trade uncertainty, fiscal stimulus, and institutional trust erosion create complex backdrop. Key opportunities emerge in AI infrastructure, defense spending, utilities transformation, and sports entertainment. Firm remains cautious on market multiples while finding value in domestic small caps and international markets. Volatility benefits patient capital deployment. |
| Mar 31 2025 | 2025 Q1 | AB, AZEK, BECN, FOXA, FYBR, GABCX, ITCI, IVAC, JNJ, JNPR, KKR, LEN, LGTY, TGNA, TXNM, VZ, WBA | Acquisitions, arbitrage, Event-Driven, Mergers, Regulatory | - | The Gabelli ABC Fund employs arbitrage strategies focused on merger and acquisition opportunities. Q1 2025 saw $885 billion in global M&A activity despite regulatory headwinds under the new Trump administration. The fund benefited from deals like Johnson & Johnson's $14.6 billion acquisition of Intra-Cellular Therapies, while positioning for continued M&A acceleration driven by competitive pressures and available private equity capital. |
| Dec 31 2024 | 2024 Q4 | ALE, AXNX, CNHI, CTLT, FOX, JNPR, KKR, LEN, NAPA, NFG, SCWX, SJI, SRDX, TGNA, TXNM | arbitrage, Capital markets, Event Driven, M&A, Mergers | - | The Gabelli ABC Fund returned 1.47% in Q4 2024, benefiting from merger arbitrage strategies as global M&A activity reached $3.2 trillion. The Trump administration's expected lighter antitrust enforcement should spur deal activity after years of regulatory headwinds. The fund maintains positions in pending mergers while capitalizing on completed transactions across technology, energy, and financial sectors. |
| Sep 30 2024 | 2024 Q3 | BSX, CHUY, FOXA, FTR, INST, JNPR, K, KKR, LBTYK, LEN, MARS, PRY, SRDX, TXNM, VZ, VZIO, WIRE | arbitrage, Deal Activity, M&A, private equity, technology | - | The Gabelli ABC Fund capitalizes on robust M&A activity through arbitrage strategies in announced deals. Global M&A reached $2.3 trillion through nine months, up 16% year-over-year, led by technology sector consolidation. Fed rate cuts support deal financing while potential regulatory changes may improve transaction approval processes, creating favorable conditions for the Fund's event-driven investment approach. |
| QUARTER | THEMES | TAGS |
|---|---|---|
| 2026 Q2 |
Biopharma M&AGlobal M&A activity remained vibrant and hit multiple records in the first half of 2026, driven by larger deal sizes and a surge in mega-transactions. Worldwide announced M&A value reached an all-time high of US$2.85 trillion during the first half of 2026, a 50% increase year-over-year. The second quarter alone delivered US$1.6 trillion, up 31% from the prior year, marking the fourth consecutive quarter above US$1 trillion and the largest single quarter on record. Mega-deals (over US$10 billion) hit a record half-year with 48 transactions totaling US$1.3 trillion, more than double 2025 levels. |
M&A Mega-deals Transactions Biotech Pharma |
Capital MarketsIn terms of deal consideration, cash was king. Year-to-date, all-cash deals accounted for 63% of transactions, all-stock deals represented 14%, and cash-and-stock deals made up the remaining 23%. Three of the largest transactions year-to-date were private investment rounds in Anthropic and OpenAI (totaling US$140 billion). While these are not traditional M&A, historical M&A statistics have long included such large private placements. |
Cash deals Private placements AI funding OpenAI Anthropic | |
| 2026 Q1 |
Biopharma M&AStrong M&A activity in biotechnology sector with multiple deals including Gilead's acquisition of Arcellx for $115 per share, Danaher's acquisition of Masimo for $180 per share, and Merck's acquisition of Terns Pharmaceuticals for $53 per share. These transactions highlight continued consolidation in the biotech space. |
Mergers Biotechnology Acquisitions Healthcare |
EnergyEnergy sector benefited from Iran conflict driving oil prices higher. Devon Energy's $21 billion acquisition of Coterra Energy was a major deal. Energy holdings like APA Corp and ONEOK performed well during the quarter as geopolitical tensions supported commodity prices. |
Oil Natural Gas Geopolitics Iran | |
Capital MarketsM&A volume reached $1.2 trillion in Q1, up 27% from prior year, marking the third consecutive quarter exceeding $1 trillion. Technology, Energy, and Financials were top sectors for deal activity. Private equity transactions increased 41% year-over-year. |
M&A Deal Volume Private Equity Transactions | |
| 2025 Q4 |
Live SportsMario Gabelli emphasizes live entertainment and sports as major investment themes, citing massive viewership numbers and recommending Atlanta Braves Holdings, Madison Square Garden Sports, and Manchester United as core positions with significant upside potential. |
Sports Entertainment Media Valuation |
AIAI is described as transformative and accelerating across the economy, but Gabelli warns of potential disappointment for investors and compares current dynamics to late 1990s tech speculation with risks of market correction. |
Technology Semiconductors Disruption Valuation | |
Natural GasNational Fuel Gas is recommended based on substantial Appalachian Basin reserves strategically located near population centers, with the value of gas reserves being unappreciated by the market. |
Energy Utilities Infrastructure Reserves | |
GoldGold expert Caesar Bryan's fund returned 167% in 2025, with gold serving as a store of value amid monetary uncertainty and geopolitical tensions, particularly for governments seeking alternatives to dollar holdings. |
Precious Metals Store of Value Monetary Policy | |
| 2025 Q3 |
AIArtificial Intelligence continues to be the primary driver of market returns, with most of the Magnificent Seven at or near all time highs. The scale of investment in AI infrastructure continues to surpass expectations, with the five largest cloud computing platforms communicating capex plans for 2025 aggregating to approximately $380 billion. |
Infrastructure Investment Technology Cloud |
Trade PolicyTrade continues to be in flux, with the U.S. signing deals with many partners including the UK and European Union, though uncertainty remains for significant countries including China and India. The average U.S. tariff has decreased from 23% in April to 17.5% currently. |
Tariffs China Uncertainty Negotiations | |
GoldGold and bitcoin extended their rallies with gold reaching nearly $4,000 per ounce and bitcoin at $120,000, driven by fiscal concerns and search for real-asset hedges amid $37 trillion in national debt and $2 trillion annual budget deficit. |
Inflation Hedge Fiscal Debt | |
RatesThe Federal Reserve cut rates for the first time this year in September, lowering the Fed Funds rate 25 bps to 4%-4.25%, with expectations for further cuts. 10 Year U.S. Treasury yields declined during the quarter and are currently around 4.1%. |
Fed Monetary Treasury Easing | |
BuybacksMany financial institutions continued their multi-year share repurchase plans, with companies like Bank of New York Mellon repurchasing 1.4% of shares and Standard Chartered reducing share count by 2.3% in the quarter. |
Repurchase Capital Returns Allocation | |
| 2025 Q2 |
AIMajor AI infrastructure platforms remained committed to aggressive investment with the five largest global data center operators communicating 2025 capex plans aggregating to ~$330bn. Adoption of generative AI services has inflected sharply with ChatGPT's Weekly Active Users doubling since the start of the year and Alphabet's Gemini reporting 50x year-over-year growth in tokens generated. |
Data Centers Cloud Semiconductors Enterprise Software Automation |
Trade PolicyThe Three T's dominated investor attention with Trade uncertainty hampering spending decisions by businesses and consumers. Liberation Day tariffs triggered market volatility but a 90-day pause provided relief. The effective weighted average tariff rate is anticipated at nearly 18% incorporating recent bilateral trade deals. |
Tariffs Trade War Globalization Supply Chain Inflation | |
Defense SpendingEuropean defense budgets are rising sharply with 31 of 32 NATO member nations committing to boost defense spending to 5% of GDP by 2035, roughly double current levels. Companies like Saab and defense contractors are benefiting from increased spending and NATO expansion. |
NATO Military Aerospace Defense Electronics Government IT | |
Live SportsGrowing enthusiasm about the world of sports with more people buying tickets to sporting events and sports broadcasting vital to companies. Major sports leagues now allow up to 30% private-equity ownership of individual teams, increasing their value. The growth of the Hispanic market is favorable for baseball and sports gambling is growing. |
Entertainment Media Sports Betting Event Ticketing Gaming | |
Energy TransitionUtilities are responding with record capital investment in generation and grid upgrades as electricity demand grows at its fastest pace since the mid-20th century, driven by AI-powered data centers, reshoring of manufacturing, and electrification of transport. |
Renewable Developers Grid Upgrade Nuclear Energy Storage Smart Grid | |
Pet CarePet ownership has reached new highs with 94 million U.S. households now owning at least one pet, up from 82 million just two years ago. Gen Z shows a 43.5% increase in pet ownership with a notable tendency to own multiple pets, driving demand for premium products and services. |
Veterinary Pet Products Animal Health E-commerce Consumer Discretionary | |
| 2025 Q1 |
Biopharma M&AThe fund invested in Intra-Cellular Therapies, which agreed to be acquired by Johnson & Johnson for $132 cash per share, valuing the transaction at approximately $14.6 billion. This represents a significant pharmaceutical merger and acquisition opportunity. |
Johnson & Johnson Intra-Cellular Therapies pharmaceutical acquisition merger |
Capital MarketsThe fund focuses on arbitrage strategies and event-driven situations including announced mergers, spin-offs, split-ups, liquidations, and reorganizations. Regulatory scrutiny remained at the forefront with two transactions sued by DOJ and FTC within weeks of Trump's inauguration. |
arbitrage mergers acquisitions regulatory antitrust | |
| 2024 Q4 |
Capital MarketsM&A activity totaled $3.2 trillion globally in 2024, a 10% increase from 2023. Technology, energy and power, and financials were the most active sectors. Private equity-backed transactions contributed 22% to total deal volumes. The new Trump administration is expected to spur a resurgence of deal activity with less strict antitrust enforcement. |
M&A Arbitrage Deal Activity Antitrust Private Equity |
| 2024 Q3 |
Biopharma M&AThe technology sector remained the most active with $375 billion worth of new deals announced in the first three quarters of 2024, representing a 29% year-over-year increase. Notable transactions included Mars Company's agreement to acquire Kellanova for $28.8 billion and Verizon's arrangement to acquire Frontier Communications for $9.6 billion. |
M&A Technology Consolidation Deal Activity Private Equity |
| Date | Pitch Type | Author | Ticker | Company | Industry | Sub Industry | Bull / Bear | Exchange | Keywords | Action |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 18, 2026 | Fund Letters | Mario J. Gabelli | GTCH | Chart Industries, Inc. | Industrials | Industrial Machinery | Bull | New York Stock Exchange | acquisition, arbitrage, energy, Industrials, LNG | Login |
| Feb 18, 2026 | Fund Letters | Mario J. Gabelli | EXAS | Exact Sciences Corporation | Health Care | Health Care Services | Bull | NASDAQ | diagnostics, growth, Oncology, Reimbursement, Screening | Login |
| Feb 18, 2026 | Fund Letters | Mario J. Gabelli | HOLX | Hologic, Inc. | Health Care | Health Care Equipment | Bull | NASDAQ | arbitrage, cashflow, diagnostics, Imaging, private equity | Login |
| Feb 18, 2026 | Fund Letters | Mario J. Gabelli | ALE | ALLETE, Inc. | Utilities | Electric Utilities | Bull | New York Stock Exchange | arbitrage, cash, infrastructure, Regulation, utilities | Login |
| Nov 16, 2025 | Fund Letters | Mario J. Gabelli | ECG US | Everus Construction Group, Inc. | Industrials | Construction & Engineering | Bull | NYSE | backlog, construction, data centers, Electrification, infrastructure | Login |
| Nov 16, 2025 | Fund Letters | Mario J. Gabelli | OR US | OR Royalties Inc. | Materials | Precious Metals Royalty & Streaming | Bull | NYSE | Gold, low leverage, Optionality, royalties, Streaming | Login |
| Jun 30, 2025 | Fund Letters | Mario J. Gabelli | SWTX | SpringWorks Therapeutics, Inc. | Health Care | Biotechnology | Bull | NASDAQ | acquisition, Approval, arbitrage, Biotech, cashflow, Oncology, pipeline, Spread | Login |
| TICKER | COMMENTARY |
|---|---|
| CPRX | Catalyst Pharmaceuticals Inc. is a biotechnology company focused on the treatment of rare neuromuscular and neurological diseases. Angelini Pharma agreed to acquire CPRX for $31.50 per share in cash on May 7. U.S. antitrust approval has already been received. CPRX shareholders approved the transaction on July 8. The transaction is expected to close on July 15. |
| GBTG | Global Business Travel Group Inc. is a software and services company for travel, expense, and meetings & events. Long Lake Management agreed to acquire GBTG for $9.50 per share in cash on May 4. The shareholder meeting is scheduled for August 3. The transaction also remains subject to various regulatory approvals. It is expected to be completed in the second half of 2026. |
| TMHC | Taylor Morrison Home Corp. is a national community developer and homebuilder with over 350 communities concentrated in prime locations across 21 markets in 12 states. Berkshire Hathaway agreed to acquire TMHC for $72.50 per share in cash on May 31. U.S. antitrust approval has already been received. The shareholder meeting is scheduled for July 22. The transaction is expected to be completed in the second half of 2026. |
| ROKU | Roku Inc. is a television streaming platform and media company in the United States. Roku agreed to be acquired by Fox Corp. for $96.00 cash and 0.9693 shares of Fox Class A common stock per share, valuing the transaction at approximately $22 billion. The transaction is subject to shareholder, as well as regulatory approvals and is expected to close in the first half of 2027. |
| OGN | Organon & Co. is a global healthcare company with a portfolio of over 70 products across women's health and general medicines. Sun Pharmaceuticals agreed to acquire OGN for $14.00 per share in cash on April 26. The shareholder meeting is scheduled for July 23. The transaction also remains subject to various antitrust approvals. It is expected to be completed in early 2027. |
| ACA | Arcosa Inc. provides infrastructure-related products and solutions across its construction products and engineered structures segments. The Construction Products segment offers natural and recycled aggregates; specialty materials; and construction site support equipment, namely trench-shoring products. The Engineered Structures segment offers utility structures for electricity transmission and distribution, wind towers, lighting structures, and telecommunication structures. On June 22nd, CRH plc, the world's largest building materials company by revenue, announced an agreement to acquire Arcosa for $150 per share cash. While CRH's offer reflected a modest 10% premium to Arcosa's pre-deal share price, it came on the heels of Arcosa's strong year-to-date stock performance, reflecting data center driven demand for transmission structures and favorable pricing and infrastructure demand for aggregates. Arcosa now offers a good merger arbitrage return (i.e. uncorrelated cash-like return) into the deal close, expected in early 2027. |
| Ticker | Put/Call | Amount Bought | Shares Bought | % Change | Weight % |
|---|---|---|---|---|---|
| No Recent Buys Data | |||||
| Ticker | Put/Call | Amount Sold | Shares Sold | % Change | Weight % | Status |
|---|---|---|---|---|---|---|
| No Recent Sells Data | ||||||
| Industry | Prev Quarter % | Current Quarter % | Change |
|---|---|---|---|
| No industry data available | |||